| DB ID | MyCo_7189 |
| Title | COVID-19 Impairs Immune Response to Candida albicans |
| Year | 2021 |
| PMID | 33717195 |
| Fungal Diseases involved | Candida albicans infection |
| Associated Medical Condition | COVID-19 |
| Genus | Candida |
| Species | albicans |
| Organism | Candida albicans |
| Ethical Statement | Informed consent was obtained from next of kins or carers of all patients and from healthy volunteers, respectively. This study was performed after obtaining the LMU Medical Faculty ethics committee approval (#20-271 and #19-778) and conducted in agreement with the ethical norms and standards of the Declaration of Helsinki. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | PD-1+ CD4+ |
| Biomarker Full Name | PD-1+ CD4+ |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Germany |
| Cohort | Patients with pneumonia resulting from confirmed SARS-CoV-2 infection were included in this study upon admittance to the ICU, when they required intubation and ventilation. |
| Cohort No. | 11 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | Whole Blood Incubation Assay and Immune Phenotyping |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Whole Blood Incubation Assay and Immune Phenotyping |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
